Physician profile
John C Richmond
NPI 1851493928
$114,094.22
in general payments reported to CMS, 2019-2025
18 companies · $3,134 in 2025
The $3,134 reported for 2025 was more than what 77% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65K · 2020: $15K · 2021: $19K · 2022: $670 · 2023: $11K · 2024: $528 · 2025: $3,134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $1,524 · Travel and Lodging: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,670.00 |
| Food and Beverage | $1,523.57 |
| Travel and Lodging | $428.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $94,534.16 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $9,960.15 | 2020-2023 | Zilretta |
| Moximed, INC | $4,200.00 | 2023-2025 | Misha Knee System, Small, Left, Misha Knee System |
| Medical Device Business Services, INC. | $2,340.00 | 2019 | |
| Stryker Corporation | $749.58 | 2021-2025 | Inspace, Crossfire, Air |
| Depuy Synthes Sales INC. | $351.08 | 2022-2024 | Dynacord, Fms Duo, Monovisc |
| Exactech, INC. | $336.28 | 2022-2023 | |
| Smith+Nephew, INC. | $310.96 | 2021-2024 | |
| Anika Therapeutics, INC. | $265.69 | 2020-2022 | |
| Acumed LLC | $228.48 | 2020-2021 | |
| Linvatec Corporation | $185.11 | 2023 | Biobrace 23mm |
| Osteoremedies, LLC | $170.66 | 2025 | Biowash Surgical Irrigation, Remedy Spacer, Osteoboost Select 5cc |
| Bone Support INC. | $130.33 | 2020 | |
| Zimmer Biomet Holdings, INC. | $122.85 | 2021 | |
| Innovation Technologies INC | $119.28 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $48.04 | 2019 | |
| Ferring Pharmaceuticals INC. | $29.24 | 2019-2020 | |
| Bioventus LLC | $12.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Richmond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.